🚨 BIG MOVE IN DIGITAL HEALTH 🚨
@lindayaX , former CEO of X (Twitter), has just been named CEO of eMed Population Health and she’s bringing her media playbook to transform chronic care. 👇🧵
#DigitalHealth #LindaYaccarino #eMed
💡 From media mogul to health tech disruptor?
Yaccarino is taking charge of eMed, a Miami-based platform using AI diagnostics to manage chronic illnesses like obesity & diabetes with GLP-1/GIP meds (think Ozempic & Wegovy). 💉📱
#HealthcareInnovation
👩⚕️ Why it matters:
➡️ Chronic illness is a $4.1T/year problem in the U.S.
➡️ GLP-1 drugs are exploding in demand
➡️ eMed slashes costs by 50% & delivers care on-demand
➡️ Now it has a media-savvy CEO to scale it globally
#HealthTech #GLP1 #ObesityCare
🗣️ Yaccarino said:
“The healthcare industry has been disrupted by tech but not yet transformed.”
Her mission?
📲 Direct-to-consumer care
🧠 Data-powered chronic care
🌍 Global reach through employers & governments
#TechForHealth #DigitalCar
🚀 eMed started with COVID-19 testing in 2020.
Now it’s a full-stack platform for digital prescriptions, weight loss, and adherence support no clinic visit needed.
And Linda's media partnership skills? Perfect for this next phase.
#FemTech #WeightLossCare
🔗 Read more about this bold pivot and what it means for the future of patient-first digital health:
👉
techpression.com/emed-hires-…
💬 Do you think Linda Yaccarino will thrive in health tech? Drop your thoughts below.
❤️ Like, 🔁 Retweet &
👀 Follow us
@Techpressionews for more stories at the intersection of tech, health, and leadership.
#eMed #LindaYaccarino #Ozempic #Wegovy #GLP1 #HealthInnovation #DigitalTransformation #FemTech #MedTech #WeightLossJourney #StartupLeadership #Telehealth #FutureOfHealthcare